PPH16: Miriam Moscovitch-Lopatin, MassGeneral Institute for Neurodegenerative Disease

Event Date

Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering Precision Health Summit 2016.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more